KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Intuitive Surgical (ISRG) Shares Outstanding (Weighted Average) (2016 - 2025)

Intuitive Surgical (ISRG) has 17 years of Shares Outstanding (Weighted Average) data on record, last reported at $356.9 million in Q4 2025.

  • For Q4 2025, Shares Outstanding (Weighted Average) changed 0.48% year-over-year to $356.9 million; the TTM value through Dec 2025 reached $356.9 million, changed 0.48%, while the annual FY2025 figure was $356.9 million, 0.48% changed from the prior year.
  • Shares Outstanding (Weighted Average) reached $356.9 million in Q4 2025 per ISRG's latest filing, roughly flat from $356.6 million in the prior quarter.
  • Across five years, Shares Outstanding (Weighted Average) topped out at $358.5 million in Q2 2025 and bottomed at $350.2 million in Q1 2023.
  • Average Shares Outstanding (Weighted Average) over 5 years is $355.2 million, with a median of $355.6 million recorded in 2021.
  • Peak YoY movement for Shares Outstanding (Weighted Average): skyrocketed 204.46% in 2021, then dropped 2.29% in 2023.
  • A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $356.1 million in 2021, then fell by 0.11% to $355.7 million in 2022, then dropped by 1.27% to $351.2 million in 2023, then rose by 1.14% to $355.2 million in 2024, then increased by 0.48% to $356.9 million in 2025.
  • Per Business Quant database, its latest 3 readings for Shares Outstanding (Weighted Average) were $356.9 million in Q4 2025, $356.6 million in Q3 2025, and $358.5 million in Q2 2025.